Intidrol

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Intidrol

What is Intidrol? (Identity and Classification)

Intidrol is a trade name for a pharmaceutical product whose active ingredient is Methylprednisolone, classified precisely as a synthetic glucocorticoid. This substance belongs to the broader corticosteroid pharmacological family, which encompasses powerful steroid hormones.

Property Description
Active ingredient Methylprednisolone
Form Tablet, Solution/Suspension for Injection
Pharmacological class Corticosteroid / Glucocorticoid
Common use Systemic anti-inflammatory and immunosuppressive
Origin Synthetic (derived)

Methylprednisolone is not a natural substance but is chemically engineered for heightened potency compared to natural cortisol, making it an intermediate-acting systemic agent. This drug functions as a Corticosteroid Hormone Receptor Agonist, affecting gene expression. Intidrol is classified as a prescription-only drug and is a single-agent product focused on systemic effect.

Composition and Available Forms of Methylprednisolone

The entire therapeutic effect of Intidrol is derived from its sole active ingredient, Methylprednisolone. The drug is designed for systemic delivery and is consequently available in several primary dosage forms, including oral tablets and sterile solutions or suspensions intended for parenteral routes.

Glucocorticoids are established as essential agents for managing inflammatory processes, and Methylprednisolone is one of the most frequently used compounds. For instance, its injectable forms are often chosen when a rapid, potent effect is needed to address sudden, widespread inflammatory flare-ups. The injectable forms utilize derivatives like Methylprednisolone sodium succinate to ensure water solubility for rapid onset of action.

General Purpose: How Glucocorticoids Benefit the Body

The fundamental general purpose of a synthetic glucocorticoid like Methylprednisolone is to provide relief by generating a potent anti-inflammatory effect and acting as an immunosuppressive agent. By systemically interfering with the complex inflammatory cascade, the drug helps to rapidly alleviate the symptoms associated with widespread inflammatory and allergic conditions. The core benefit is the capacity to quickly suppress excessive immune activity, offering a therapeutic intervention for patients requiring management of an overactive or misdirected immune response.

Regulatory References

  1. U.S. National Institutes of Health (NIH)

What side effects are possible with Intidrol?

Possible Side Effects and Safety Information: Intidrol

Intidrol (methylprednisolone), a synthetic glucocorticoid, carries a safety profile defined by systemic adverse reactions documented in official government regulatory labels. These effects are formally categorized by the physiological systems they affect and their frequency.

Documented Adverse Reaction Scope

Adverse reactions are formally grouped by System Organ Class (SOC) in regulatory documents. Key areas include Endocrine Disorders (e.g., HPA axis suppression, Cushingoid state, hyperglycemia), Musculoskeletal System Disorders (e.g., muscle weakness, osteoporosis, tendon rupture), and Ophthalmic Disorders (e.g., posterior subcapsular cataracts, glaucoma).

Frequency Classification (Examples) Documented Adverse Reactions (Sample)
Common Fluid retention, headache, changes in menstrual periods
Not Known Increased intracranial pressure with papilledema (pseudo-tumor cerebri), severe psychiatric derangements

Critical Safety Considerations

The label identifies several serious adverse reactions. These include acute adrenal insufficiency (adrenal crisis) following abrupt cessation of long-term therapy, severe infections due to immune suppression, and the risk of peptic ulcer with perforation and hemorrhage.

Safety is also tied to exposure and population: Prolonged use is associated with long-term effects like cataracts. Pediatric use carries a risk of growth suppression. The drug is contraindicated in patients with systemic fungal infections and caution is required due to the risk of reactivation of latent diseases (e.g., tuberculosis).

This profile structures the understanding of Intidrol's risks, highlighting its systemic impact and specifying constraints based on patient status and duration of use.

Overdose and Emergency Response

The official regulatory documents state that reports of acute toxicity following Intidrol (Methylprednisolone) overdosage are rare, and no clinical syndrome of acute overdosage is formally recognized. However, severe, life-threatening manifestations are documented, particularly associated with the rapid intravenous administration of high doses (e.g., greater than 500 mg over 10 minutes).

Key documented manifestations and severe outcomes include effects on the cardiovascular system. Specifically, cardiac arrhythmias, bradycardia, circulatory collapse, and cardiac arrest have been reported in this specific context. Furthermore, acute signs necessitating emergency action are the occurrence of a seizure, collapse, or trouble breathing.


When to Seek Immediate Medical Help

Regulatory guidance mandates that patients or caregivers seek immediate medical attention for any suspected overdose event. It is required to immediately call emergency services (911) if the individual has collapsed, is experiencing trouble breathing, exhibits a seizure, or is unable to be awakened.


Overdose Management

Management of acute overdosage is defined as supportive and symptomatic therapy. The official labeling confirms that no specific antidote is available for Intidrol overdose. The substance is documented as being dialysable. For documented cases of chronic overdosage resulting from prolonged high-dose use, procedural management involves procedures such as temporary dosage reduction or the introduction of alternate day treatment.

Therapeutic Uses of Intidrol

What Intidrol Treats: Main Uses and Benefits


The medication is applied across therapeutic domains where relief for symptoms related to physical discomfort is needed in scenarios where symptoms are severe or where symptoms create noticeable physiological strain. Its use is relevant in contexts involving heightened systemic burden across numerous specialty domains.

Managing Acute Crises in Systemic Autoimmune Conditions

Intidrol is commonly used to address severe flare-ups associated with conditions characterized by periods of heightened symptoms, such as rheumatoid arthritis, systemic lupus erythematosus, and psoriatic arthritis. It is applied when symptoms relate to systemic imbalance and widespread physical discomfort, providing supportive relief that helps ease the overall symptom burden during these critical episodes.

Supportive Relief in Acute Allergic and Organ-Specific Stress

This medication offers supportive symptomatic relief in situations marked by symptoms associated with acute or episodic changes, including intractable asthma exacerbations, drug hypersensitivity, and acute crises of inflammatory bowel disease (IBD). It also assists with maintaining functional stability and contributes to improved comfort when symptoms interfere with routine activities.


Quick Fact: Supportive Relief for Symptoms of Heightened Strain

Eligibility and Restrictions for Use

This section summarizes the official eligibility and non-eligibility information for Intidrol as defined by regulatory authorities.

Populations Who Must Not Use Intidrol

Intidrol is formally contraindicated in two main groups:

  • Individuals with a known hypersensitivity (severe allergic reaction) to the active substance or any other component in the formulation.
  • Patients with an untreated active systemic fungal infection.

Additionally, the use of live or live-attenuated vaccines is contraindicated for patients receiving immunosuppressive doses of Intidrol.

Eligibility-Related Restrictions

Population Group Regulatory Status and Condition
Pediatric Use Efficacy and safety are often stated as not established in specific age groups. Long-term use requires monitoring for potential effects on growth.
Pregnancy/Lactation Use is conditional; it is allowed only if the potential benefit justifies the potential risk to the fetus, as documented in the label.
Organ Impairment Patients with severe hepatic or renal impairment are eligible only under strict caution and may require mandatory dose adjustment, as specified in the prescribing information.
Other Conditions Use requires caution and monitoring in patients with conditions such as active or latent tuberculosis, peptic ulcer disease, diverticulitis, and ocular herpes simplex.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Intidrol (Methylprednisolone) establishes specific restrictions and pharmacokinetic considerations regarding co-administered substances.

Formal Regulatory Restrictions The administration of live or live, attenuated vaccines is formally contraindicated when Intidrol is used at immunosuppressive dosages. The drug is also contraindicated for use in patients officially diagnosed with systemic fungal infections.

Pharmacokinetic Alterations (Exposure) Methylprednisolone clearance is mediated primarily by the CYP3A4 enzyme system. Co-administration with CYP3A4 inhibitors (e.g., Ketoconazole, Erythromycin) results in decreased clearance, officially documented to increase the drug's plasma concentration. Conversely, CYP3A4 inducers (e.g., Rifampin, Phenytoin) increase clearance, which may reduce Intidrol's systemic exposure. Additionally, Oral Contraceptives containing estrogens are documented to increase the half-life and plasma levels of the corticosteroid.

Pharmacodynamic and Substance Effects Co-administration with Non-steroidal Anti-inflammatory Drugs (NSAIDs) is associated with an officially documented increased risk of gastrointestinal side effects. Concurrent use with potassium-depleting agents (e.g., diuretics) raises the documented risk of hypokalemia. Intidrol has a variable, unpredictable effect on coumarin anticoagulants (e.g., Warfarin), altering the anticoagulant effect. A drug-food interaction is documented with Grapefruit Juice, which increases the drug’s concentration. An enhanced effect of the corticosteroid is also officially noted in populations with hypothyroidism or cirrhosis.

Mechanism of Action

How Intidrol Works: Mechanistic Domains

Intidrol operates through the specific modification of receptor- or enzyme-mediated signaling, engaging mechanisms that influence the activity of processes within targeted biological systems. Its mechanism-of-action is defined by two principal functional domains.


Modification of Core Signaling Sequences

This domain details the compound's capacity to initiate or suppress specific signaling sequences, resulting in downstream molecular effects. It involves altering pathway activity by modifying early molecular steps that influence subsequent cellular and network activity. The action results in a reduced activation state within the affected molecular pathways.


Interactions with Key Transmitters and Mediators

Intidrol modifies activity within pathways where specific neurotransmitters or mediators are central, influencing the processes governed by these signaling patterns. It engages mechanisms that affect feedback regulation within pathways. The compound influences the net availability or action of specific signaling mediators, leading to an altered steady-state activity within targeted molecular systems.

Dosage and Administration Information

Intidrol, which contains the active ingredient Methylprednisolone, is administered through specific routes defined by its physical form. The usage protocol is characterized by a precise, multi-stage dose schedule that dictates both the initial starting amount and the required method of discontinuation.

Administration Scope and Official Dosing

The medication is available as oral tablets and sterile preparations for parenteral administration (IV/IM/local injection).

Instruction Category Guidelines
Route of Administration Oral (for tablets). Intravenous (IV) or Intramuscular (IM). Local administration (e.g., intra-articular) for specific suspensions.
Dosing Schedule Logic Initial doses (e.g., 4 mg to 48 mg daily) must be followed by a gradual dose reduction (tapering) to reach the lowest effective maintenance dose.
Frequency Pattern Typically once daily or divided doses for oral use. High-dose IV pulse therapy is short-term (e.g., 3 to 5 days). Long-term use may involve Alternate Day Therapy.
Special Procedures High-dose IV infusions (>250 mg) require a minimum administration time of 30 minutes. The use of certain injectable formulations is prohibited in neonates and for intrathecal/epidural routes.

The structure of Intidrol's use protocol is centered on the principle of systematic withdrawal. Following the initial therapeutic phase, the entire duration of exposure is governed by the need for a systematic, gradual reduction instead of immediate discontinuation. If an oral dose is missed, it should be taken as soon as possible, but doubling the subsequent dose is not permitted.

Recent Clinical Evidence

Intidrol: Recent Clinical Evidence

Intidrol (Methylprednisolone) was studied in research contexts involving actions related to controlling inflammation and immune processes. The evidence base primarily relies on Randomized Controlled Trials (RCTs) and Systematic Reviews. This overview describes what researchers studied, what their findings describe patterns related to, and what remains uncertain, based on official sources.

Evidence for Use in Systemic Inflammatory and Autoimmune Flare-ups

Research for Intidrol was studied for use in contexts where symptoms are related to systemic imbalance, such as acute flare-ups of chronic inflammatory conditions like rheumatoid arthritis and severe asthma exacerbations. The research explored numerous short-term RCTs and systematic reviews which included both Adults and Children. These studies were conducted during periods of increased symptom activity and evaluated outcomes related to physical discomfort and functional scales reflecting daily functioning.

Findings describe patterns observed in measured symptom change and functional status across numerous distinct inflammatory conditions. A key limitation is that the evidence quality varies across studies, and findings may be heterogeneous. There is limited information for long-term outcomes related to chronic disease modification.

Evidence for Use in Progressive Kidney Disease

Research for Intidrol in specific chronic conditions, such as IgA Nephropathy, is supported by high-quality evidence from major Multicenter Randomized Controlled Trials and their long-term observational follow-up studies. Researchers focused on hard clinical events, exploring outcomes related to the prevention of kidney failure and tracking a reduction in kidney function over time in Adults with kidney impairment.

Long-term data gathered from observational settings describe patterns associated with a measured difference in the rate of kidney function decline compared to control groups. However, initial findings described serious adverse event patterns observed with specific high-dose regimens. The results apply only to the populations studied and would benefit from independent replication.

Evidence for Use in Acute Critical Illness

The research structure for this area is based on Systematic Reviews and Meta-analyses that aggregate data from multiple smaller RCTs conducted in intensive care units (ICUs), such as for patients with severe pneumonia or Acute Respiratory Distress Syndrome (ARDS). Studies monitored outcomes related to short-term mortality rates and the duration of mechanical ventilation. Overall certainty remains low to moderate due to inconsistent findings and methodological heterogeneity across trials.

Key Studies & References

  1. NIH DailyMed: Methylprednisolone Tablet and Injection Product Information
  2. Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy (TESTING): a multicentre, randomised, double-blind, placebo-controlled trial

Frequently Asked Questions (FAQ)

Common questions about Intidrol (FAQ)


Q: What is the main reason doctors prescribe Intidrol?

A: Intidrol is a type of steroid prescribed by healthcare professionals for its systemic anti-inflammatory and immunosuppressive properties. Official documents state that it is used to manage and treat symptoms across many different conditions, including those affecting the endocrine system, rheumatic disorders, allergic states, and certain dermatologic and respiratory diseases.


Q: Does Intidrol have to be taken with food?

A: The oral tablet form of Intidrol is often described in official patient information as being taken with food or milk, or alongside breakfast. This practice is typically advised to help reduce the possibility of stomach irritation that may occur with the medication.


Q: How long does it usually take to feel the effects of Intidrol?

A: Pharmacokinetic studies indicate that after taking Intidrol orally, the active ingredient typically reaches its maximum concentration in the blood within about 1.5 to 2.3 hours. However, the time until the therapeutic benefit is observed can vary widely based on the specific condition being addressed.


Q: Why do some people say Intidrol makes them feel dizzy?

A: Dizziness or vertigo (a sensation of spinning or whirling) is listed in official documents as a potential adverse reaction to the active ingredient in Intidrol. If dizziness is persistent or concerning, reviewing the situation with a healthcare professional is generally advisable.


Q: Can Intidrol affect sleep patterns?

A: Yes, official safety information states that the active ingredient may cause psychic derangements, which can include insomnia (difficulty sleeping). These effects may also present as mood swings or other changes in personality.


Q: What age groups is Intidrol typically used for?

A: Intidrol is indicated in official labeling for use in both adults and children for specific conditions. Official guidance emphasizes that for children receiving long-term treatment, monitoring for potential effects on growth and development is specified.


Q: Are headaches a commonly reported side effect of Intidrol?

A: According to official regulatory labeling on adverse reactions, headache is one of the effects that has been commonly reported with the use of the active ingredient found in Intidrol.


Q: What should I do if I experience an unexpected reaction to Intidrol?

A: Official patient safety information advises that a healthcare professional be contacted immediately upon developing any new, severe, or unexpected symptoms while using Intidrol. This allows for a necessary medical review to be conducted.


Q: How long does Intidrol stay in the body after the last use?

A: Pharmacokinetic data shows that the mean elimination half-life of the active ingredient in the body is generally in the range of approximately 1.8 to 5.2 hours. This half-life describes the time required for half of the drug to be eliminated from the body.


Q: Is Intidrol known to cause mood changes?

A: Yes, official safety warnings describe that the active ingredient may cause psychic derangements. These changes can range from minor issues like mood swings and euphoria to more serious concerns like severe depression or psychosis.


Q: Does Intidrol interact with alcohol?

A: Official documents do not list a formal, direct drug-alcohol interaction. However, alcohol consumption may potentially increase the risk of certain documented side effects, such as gastrointestinal irritation or ulceration, and it may also impact mood or mental status.


Q: Are there any known interactions between Intidrol and common cold medicines?

A: Official drug interaction sections document risks with certain drug classes, such as non-steroidal anti-inflammatory drugs (NSAIDs) or certain liver enzyme inhibitors (CYP3A4 inhibitors). Since some common cold medicines may contain these agents, any potential combination warrants review by a healthcare professional.


Q: Why is it important to take Intidrol regularly?

A: Taking Intidrol regularly is essential because the drug is used either to rapidly control an acute condition or to maintain a specific therapeutic effect over time. Consistent use is considered necessary to maintain stable blood levels required to achieve the intended therapeutic effect.


Q: What does 'Intidrol is not for everyone' mean in official warnings?

A: This official warning highlights that the medication has formal contraindications, meaning specific conditions where it must never be used (like systemic fungal infections). It also points to the extensive list of warnings and precautions for patients with certain pre-existing health issues, such as high blood pressure or diabetes.


Q: Is it common to feel tired when starting Intidrol?

A: Official adverse reaction reports indicate that unusual tiredness or weakness is listed as a potential symptom associated with the use of the active ingredient. The incidence of side effects is often related to the specific dosage and the length of time Intidrol is being taken.


Q: Can Intidrol affect the results of certain lab tests?

A: Yes, official warnings state that Intidrol may potentially interfere with the results of certain laboratory tests. For example, it may affect the outcomes of skin tests or influence results related to blood glucose or certain mineral levels.


Q: How does Intidrol affect the kidneys?

A: The drug can lead to salt and water retention in the body, which may contribute to higher blood pressure. Because of these potential effects, use of Intidrol in patients with existing renal insufficiency (impaired kidney function) is noted in regulatory documents as requiring caution.


Q: Are there any dietary restrictions mentioned for Intidrol?

A: Official information often describes dietary considerations to help manage potential side effects. Patients may be advised to limit sodium (salt) intake to help prevent fluid retention or to monitor high-calorie or sugary foods due to the risk of the drug causing high blood sugar.


Q: Is it normal to have mild side effects when first starting Intidrol?

A: Many of the common side effects of Intidrol, such as fluid retention or increased appetite, are often observed in the initial phase of treatment. The likelihood of experiencing these effects is often linked to the dosage being used and the total duration of the therapy.


Q: How is Intidrol different from an antibiotic?

A: Intidrol is officially classified as a glucocorticoid, a type of steroid that works by modulating the body's inflammatory and immune responses. An antibiotic, in contrast, is a type of drug specifically designed to kill or inhibit the growth of bacteria and does not affect the body's immune response in the same way.


Q: Does Intidrol interact with common herbal products like St. John's Wort?

A: Yes, regulatory documents describe a potential interaction risk with certain herbal products. Specifically, the active ingredient can interact with herbal remedies, such as St. John's Wort, that are known to induce (speed up) the activity of the CYP3A4 enzyme, which may reduce the drug's concentration and its therapeutic effect.


Q: What are the rules about driving or operating machinery while on Intidrol?

A: Official safety documents caution that the drug can cause adverse reactions, such as dizziness, vertigo, or psychiatric disturbances. Because these effects may impair the ability to react, caution is advised when driving or operating machinery while undergoing treatment.


Q: Is Intidrol safe to use if I have high blood pressure?

A: Official patient eligibility sections advise caution and monitoring for patients with pre-existing conditions. Intidrol may cause side effects like fluid retention, which can be linked to increases in blood pressure, making careful observation necessary for patients with existing hypertension.


Q: Can Intidrol cause changes in appetite or weight?

A: Official safety documentation notes that the drug may be associated with endocrine changes that can lead to a Cushingoid state, and fluid retention is a common side effect. These factors are often linked to changes in weight, and increased appetite is a reported observation.


Q: How is Intidrol different from [similar competitor drug name]?

A: Intidrol's active ingredient, Methylprednisolone, is classified as a synthetic glucocorticoid. The drug is described as an intermediate-acting agent within this class. The primary distinctions between it and other similar steroids are often based on its relative potency, duration of action, and specific formulation.


Q: Is Intidrol used for any other conditions besides its main purpose?

A: Intidrol's official uses cover a wide range of conditions beyond its primary systemic anti-inflammatory purpose. Clinical evidence and regulatory labeling indicate it has been studied for conditions such as specific chronic kidney diseases, severe asthma exacerbations, and acute inflammatory disorders.


Q: Can Intidrol be used by people who have diabetes?

A: Official warnings state that one of the potential adverse reactions to Intidrol is an endocrine disorder, specifically hyperglycemia (high blood sugar). Therefore, use in individuals with pre-existing diabetes or a history of blood sugar issues is specified in the label as requiring caution and monitoring.


Q: What happens if Intidrol is stopped suddenly?

A: If the medication is stopped abruptly after a period of use, the body may experience physiological changes. Regulatory safety warnings cite the risk of acute adrenal insufficiency (adrenal crisis) following the sudden cessation of therapy, which is why official administration guidelines mandate a systematic, gradual dose reduction (tapering).


Q: What are the most frequent reasons people stop taking Intidrol?

A: Patients may discontinue treatment for various reasons, often due to the resolution of the acute condition it was prescribed for. However, discontinuation may also occur due to adverse events, ranging from more common side effects to the incidence of serious reactions cited in clinical trials, such as severe infections or cardiovascular events.


Q: Can Intidrol be taken alongside pain relievers like ibuprofen?

A: Official drug interaction warnings advise caution when Intidrol is taken concurrently with NSAIDs (Non-steroidal Anti-inflammatory Drugs), a class that includes ibuprofen. This combination is formally associated with a documented increased risk of gastrointestinal side effects.

How should Intidrol be stored and disposed of?

How to Store and Dispose of Intidrol?

Official labeling for Intidrol mandates specific conditions to maintain product quality and efficacy until its expiration date.

Mandatory Storage Requirements

Storage Factor Regulatory Requirement
Temperature Store at the precise temperature range specified on the label, typically at controlled room temperature, and do not exceed the maximum allowed temperature.
Protection Keep the medicine in its original container and outer carton to protect it from light and moisture, ensuring the lid or closure is tightly sealed.
Handling Store Intidrol out of the reach of children. If the product requires reconstitution, use the solution within the labeled stability period and temperature (e.g., 24 hours).

Disposal Instructions

Do not dispose of expired or unused Intidrol by pouring it down a sink or toilet. Proper disposal involves following governmental and local regulations, which often require returning the medicine to a drug take-back program or an authorized collection site to ensure compliance with environmental guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Intidrol found in:

A-Z Index: